Article Details
Retrieved on: 2025-09-20 21:14:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Following treatment with remibrutinib, CUI+ patients demonstrated significant reductions in FcεRI- and TG-specific IgG levels compared with placebo at ...
Article found on: www.dermatologytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here